Proteomic Solution for Pet Antibody Target Discovery

Are you currently facing challenges in identifying novel and effective targets for your veterinary therapeutic antibody programs? The complexity of animal disease pathology and the limitations of conventional methods can lead to long development cycles and a low probability of success. Creative Biolabs' proteomic solution for pet antibody target discovery helps you accelerate your veterinary drug discovery by identifying high-value antibody targets directly from relevant biological samples. Through advanced mass spectrometry-based proteomics and sophisticated bioinformatics, we provide a clear path to novel therapeutic opportunities.

Proteomic Antibody Target Discovery Service Introduction

Creative Biolabs translates complex biological systems into actionable data. Our service is designed to meticulously identify and validate novel protein targets on the surface of diseased cells or within pathological tissues from companion animals. We empower your research by delivering a ranked list of potential antibody targets, complete with expression data and biological context, significantly de-risking your downstream antibody development efforts. Our team of experts works with you to understand your specific research goals and tailor the proteomic strategy to best suit your project's needs.

Pet Antibody Target Proteomics Discovery. (Creative Biolabs Authorized)

Request a Consultation

Workflow of Transcriptomic based Antibody Target Discovery

Choosing Creative Biolabs means partnering with a dedicated team of specialists committed to the success of your veterinary therapeutic antibody discovery programs. Our process is a transparent and collaborative journey from sample to insight, designed for clarity and efficiency.

Pet Antibody Target Proteomics Discovery Workflow. (Creative Biolabs Original) Fig. 1 Proteomic Pet Antibody Target Discovery Workflow. (Creative Biolabs Original)

1. Project Consultation and Design	We begin with a deep dive into your project goals, discussing the disease model, sample types, and desired outcomes to design a bespoke proteomic strategy.
2. Sample Preparation & Quality Control	Samples undergo rigorous quality assessment. Proteins are extracted, and for cell surface proteomics, specific enrichment protocols are employed to isolate membrane-associated proteins.
3. Proteomics Analysis	Our comprehensive services transform your biological samples into actionable data. The process begins with meticulous sample preparation and protein digestion, followed by analysis using high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS). Sophisticated bioinformatics then processes this complex data to deliver a final report, providing clear identification and quantification of key proteins.
4. Final Deliverables	A detailed project report outlining the methods, quality control metrics, and a summary of findings. A complete list of identified and quantified proteins with their statistical significance. A prioritized list of potential antibody targets, annotated with information on cellular localization, expression levels, and known biological functions.

Proteomics Services

(Creative Biolabs Authorized)

Global and Differential Proteomics

These services provide a large-scale, unbiased view to discover potential targets by comparing protein expression between samples. This initial screening is vital for generating a broad list of candidate proteins that are upregulated in disease. Services include: shotgun proteomics, label-free quantification, and isobaric labeling (TMT/iTRAQ).

Specialized Proteomics

To isolate the most valuable targets, these services enrich for proteins in specific cellular locations ideal for antibody binding. The focus is on identifying accessible proteins on the cell exterior or those released from the cell. Services include: cell surface proteomics, secretome analysis, and exosome proteomics.

Targeted and Functional Proteomics

Once candidates are found, these high-sensitivity services validate their potential and explore their biological context. They confirm target expression and function, ensuring only the most promising candidates advance. services include: targeted proteomics, PTM analysis, protein-protein interaction analysis, etc.

Why Choose Us?

Veterinary-Specific Expertise
We specialize in companion animal proteomics. We understand the unique challenges, from species-specific sequence databases to the nuances of veterinary disease models, ensuring more relevant and accurate data.
Advanced High-Resolution Mass Spectrometry
We utilize state-of-the-art Orbitrap mass spectrometers, providing superior sensitivity, resolution, and accuracy. This allows us to identify low-abundance proteins and post-translational modifications that are often missed by other platforms, yet critical for target discovery.
Integrated Bioinformatics for Actionable Insights
Our bioinformatics pipeline is tailored for target discovery, focusing on identifying cell-surface and secreted proteins that are differentially expressed in disease. We deliver not just lists of proteins, but prioritized, biologically-annotated targets ready for the next stage of validation.

FAQs

1. What types of samples are best for discovering antibody targets?

For antibody target discovery, the ideal samples are typically diseased tissues and their healthy counterparts, or specific cell populations isolated from these tissues. This direct comparison allows us to identify proteins that are uniquely or more highly expressed in the disease state. We can certainly guide you on the best sampling strategy for your specific research question.

2. How does this proteomics approach compare to a transcriptomics (RNA-Seq) approach for target discovery?

They are highly complementary. While RNA-Seq tells you which genes are being transcribed, proteomics tells you which proteins are actually being produced and at what level. Since proteins are the functional players and the direct targets of antibodies, proteomics provides a more direct and functionally relevant dataset for this application.

3. What is the main advantage of using your service over setting this up in-house?

The primary advantages are expertise and technology. Setting up a high-resolution proteomics platform is a significant investment in equipment and highly specialized personnel. We provide immediate access to a state-of-the-art facility and a team of scientists with years of experience specifically in veterinary proteomics and target discovery, saving you time and resources while ensuring high-quality, reproducible results.

Related Services

To further support your veterinary drug discovery pipeline, Creative Biolabs offers a suite of complementary services.

Genomic Solution

We provide comprehensive analysis of an organism's complete set of DNA to identify genetic markers and variations associated with disease.

Transcriptomics Solution

Integrate transcriptomic (RNA-Seq) data to correlate gene expression with protein abundance for a multi-omic view of your target.

In Silico Target Screening

Utilize computational tools to further assess the suitability of your top protein candidates before committing to lab-based validation.

High-Throughput Target Screening

Once targets are identified, use our screening platforms to validate their role in disease and test the efficacy of potential pet therapeutic leads.

Partner with Creative Biolabs

Creative Biolabs is your dedicated partner in advancing animal therapeutic antibody R&D. Our proteomic solution for pet antibody target discovery is designed to provide the critical data and insights you need to fuel your therapeutic pipeline with high-quality, validated targets.

Ready to uncover the next generation of veterinary antibody therapies? Our team is available to discuss your project in detail and design a tailored solution. Contact Our Team

Contact Our Team

Services